Germline missense, truncating, and splice site variants in RECQL1 have been enriched in participants with breast cancer in five different ethnic groups (Cybulski et al., 2015; Sun et al., 2015; Kwong et al., 2016; Sun et al., 2017; Tervasmaki et al., 2018). Here, RECQL is linked to breast cancer.